Skip to Content


In the US, Bosentan (bosentan systemic) is a member of the drug class agents for pulmonary hypertension and is used to treat Pulmonary Hypertension.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of pulmonary hypertension

Endothelin receptor antagonist

Chemical Names

Benzenesulfonamide, 4-(1,1-dimetyletyl)-N-[6-(2-hydroxyetoxy)-5-(2-metoxyphenoxy)[2,2'-bipyrimidin]-4-yl] (USAN)

p-tert-butyl-N-[6-(2-hydroxyetoxy)-5-(o-metoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide (WHO)

Foreign Names

  • Bosentanum (Latin)
  • Bosentan (German)
  • Bosentan (French)
  • Bosent├ín (Spanish)

Generic Names

  • Bosentan (OS: BAN, USAN)
  • Ro 47-0203 (IS)
  • Bosentan Hydrate (OS: JAN)
  • Ro 47-0203/029 (IS)
  • UNII-Q326023R30 (IS)

Brand Names

  • Bopaho
    Sanofi-Aventis, Slovenia; Zentiva, Poland
  • Bosentan Accord
    Accord, Netherlands
  • Bosentan Celon
    Celon, Poland
  • Bosentan PI
    Pharmascience, Netherlands
  • Bosentan Sandoz
    Sandoz, Poland
  • Bosentas
    Cipla, India
  • Lupibose
    Lupin, India
  • Stayveer
    Marklas Nederland, Poland; Marklas Netherland, Slovenia
  • Tansnura
    Sigillata, Netherlands
  • Tracleer
    Actelion, China; Actelion, Denmark; Actelion, Greece; Actelion, Hong Kong; Actelion, Poland; Actelion, Romania; Actelion, Singapore; Actelion, Thailand; Actelion, Turkey; Actelion, Taiwan; Actelion Pharmaceuticals, Israel; Biotoscana, Argentina; Biotoscana, Colombia; Haupt Pharma Wulfing, Lebanon
  • Bosentan Accord
    Accord Healthcare, Estonia
  • Bosentan Norameda
    GE Pharmaceuticals Ltd, Bosnia & Herzegowina; Norameda, Estonia
  • Bosentan Sandoz
    Sandoz, Estonia
  • Pahsentan
    Hanmi, South Korea
  • PMS-Bosentan
    AFT, New Zealand; Pharmascience, Canada
  • Sandoz Bosentan
    Sandoz, Canada
  • Sentoba
    PharmaSwiss, Estonia
  • Tracleer
    Actelion, Australia; Actelion, Belgium; Actelion, Canada; Actelion, Switzerland; Actelion, Czech Republic; Actelion, Germany; Actelion, Spain; Actelion, Finland; Actelion, France; Actelion, Hungary; Actelion, Ireland; Actelion, Iceland; Actelion, Italy; Actelion, Lithuania; Actelion, Latvia; Actelion, Netherlands; Actelion, Norway; Actelion, Portugal; Actelion, United States; Actelion, Vietnam; Actelion Pharmaceuticals, Japan; Actelion Pharmaceuticals, Serbia; Actelion Pharmaceuticals, Russian Federation; Actelion Pharmaceuticals, Sweden; Actelion Pharmaceuticals Mexico, Mexico; Actelion Pharmaceuticals UK, Austria; Actelion Pharmaceuticals UK, United Kingdom; Biotoscana Farma, Chile; Healthcare Logistics, New Zealand; Medis Adria, Croatia (Hrvatska)
  • Usenta
    Tecnofarma, Chile


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.